Bliss GVS Pharma Limited (NSE:BLISSGVS)

Bliss GVS Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	1,510	351.42	237.94	231.4	249.55	219.15
Short-Term Investments	416.32	1,520	1,176	1,167	384.44	1,130
Trading Asset Securities	-	14.46	-	5.57	49.6	-
Cash & Short-Term Investments	1,927	1,886	1,413	1,404	683.59	1,349
Cash Growth	-3.96%	33.46%	0.70%	105.34%	-49.34%	118.83%
Accounts Receivable	5,669	5,172	4,388	4,043	3,852	3,928
Other Receivables	-	90.54	88.82	134.02	57.8	119.38
Receivables	5,669	5,263	4,477	4,178	3,910	4,048
Inventory	1,883	1,507	1,257	1,184	1,031	1,239
Prepaid Expenses	-	41.7	24.7	27.76	24.21	31.9
Other Current Assets	510.31	765.17	1,066	1,315	1,325	1,100
Total Current Assets	9,990	9,463	8,238	8,109	6,974	7,769
Property, Plant & Equipment	4,695	4,567	4,177	3,694	3,729	2,948
Long-Term Investments	38.62	339.37	310.67	80.2	568.59	36.75
Goodwill	77.11	77.11	77.11	77.11	77.11	77.11
Other Intangible Assets	6.82	2.14	2.3	1.07	2.29	3.83
Long-Term Deferred Tax Assets	80.5	163.01	-	-	33.33	-
Other Long-Term Assets	935.34	311.87	207.29	154.99	184.42	252.93
Total Assets	15,823	14,924	13,013	12,116	11,569	11,087

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	1,223	1,042	714.18	609.65	863.9	926.06
Accrued Expenses	41.62	133.87	70.43	58.08	55.09	47.86
Short-Term Debt	-	27.53	228.92	324.17	460.14	607.03
Current Portion of Long-Term Debt	-	1.73	282.37	197.98	113.63	210.32
Current Portion of Leases	57.25	55.23	44.1	27.55	11.14	9.42
Current Income Taxes Payable	329.38	300.04	37.74	18.66	26.56	66.49
Current Unearned Revenue	-	61.78	45.7	69.24	34.7	90.08
Other Current Liabilities	647.48	733.16	298.21	268.73	367.44	373.6
Total Current Liabilities	2,298	2,355	1,722	1,574	1,933	2,331
Long-Term Debt	-	-	198.46	355.92	406.9	232.22
Long-Term Leases	168.32	133.01	127.19	92.79	27.17	34.92
Long-Term Unearned Revenue	0.14	0.2	0.47	0.61	0.74	0.87
Pension & Post-Retirement Benefits	-	20.66	33.63	26.74	26.89	10.74
Long-Term Deferred Tax Liabilities	-	-	3	35.93	-	13.23
Other Long-Term Liabilities	42.44	97.25	10.01	-	-	-
Total Liabilities	2,509	2,607	2,094	2,086	2,394	2,623

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	106.33	105.79	105.37	104.69	104.15	103.68
Additional Paid-In Capital	-	447.88	404.24	331.64	269.94	212.77
Retained Earnings	-	11,312	10,120	9,324	8,603	7,941
Comprehensive Income & Other	12,797	63.79	-126.06	-88.46	-138.53	-70.73
Total Common Equity	12,903	11,929	10,504	9,672	8,839	8,187
Minority Interest	410.44	388.6	414.71	357.9	335.27	277.6
Shareholders' Equity	13,314	12,318	10,918	10,030	9,174	8,465
Total Liabilities & Equity	15,823	14,924	13,013	12,116	11,569	11,087

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	225.57	217.5	881.04	998.4	1,019	1,094
Net Cash (Debt)	1,701	1,669	532.41	405.27	-335.39	255.5
Net Cash Growth	14.84%	213.45%	31.37%	-	-	-
Net Cash Per Share	15.71	15.51	5.02	3.82	-3.18	2.43
Filing Date Shares Outstanding	106.2	105.79	105.37	104.69	104.15	103.68
Total Common Shares Outstanding	106.2	105.79	105.37	104.69	104.15	103.68
Working Capital	7,691	7,108	6,517	6,535	5,041	5,438
Book Value Per Share	121.50	112.76	99.68	92.39	84.87	78.97
Tangible Book Value	12,820	11,850	10,424	9,594	8,760	8,106
Tangible Book Value Per Share	120.71	112.01	98.93	91.64	84.10	78.19
Land	-	434.67	422.36	409.88	419.83	420.09
Buildings	-	1,465	1,360	1,369	1,437	1,059
Machinery	-	3,740	3,152	2,616	2,580	1,809
Construction In Progress	-	60.46	207.11	78.27	28.01	221.55

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error